|
MechanismHIV-1 pol inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseNDA/BLA |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Matrix Labs LLC
0 Patents (Medical) associated with Matrix Labs LLC
100 Deals associated with Matrix Labs LLC
100 Translational Medicine associated with Matrix Labs LLC